Cannabis company Tilray shares jump 11% after announcing deal with Swiss drugmaker Novartis

The marijuana company would work with Novartis' generic drug business Sandoz, and supply non-smokable and non-combustible medical cannabis products where it is legally allowed.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.